Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc. (NYSE: ARE), primarily known as a leading real estate investment trust (REIT) focused on collaborative life science, technology, and agtech campuses, also operates a highly active and strategic venture capital arm, Alexandria Venture Investments. Established in 1996, this dedicated investment vehicle plays a crucial role in fostering innovation within the sectors where Alexandria has significant real estate presence. The venture arm leverages Alexandria's extensive network and real estate platform to support its portfolio companies, often providing laboratory and office space solutions alongside capital.

Alexandria Venture Investments strategically invests across various stages, from seed and early-stage rounds to growth-stage financing. Their investment philosophy is deeply rooted in identifying and supporting companies that are developing groundbreaking technologies and therapies, aligning with Alexandria's mission to advance human health and sustainable agriculture. The firm is particularly active in capital-intensive sectors like biotechnology, pharmaceuticals, and agricultural technology, where significant funding is required for research, development, and commercialization.

The venture arm boasts an impressive track record, having invested in over 75 companies that have successfully gone public or been acquired since its inception. Furthermore, over 80 companies within their portfolio have achieved unicorn status or greater, underscoring their ability to identify and nurture high-growth potential. In 2021 and 2022 alone, Alexandria Venture Investments saw 20 IPOs and M&A events from its portfolio companies, demonstrating a consistent record of successful exits. Their portfolio includes industry leaders such as Moderna and Intellia Therapeutics, highlighting their participation in transformative companies.

As a strategic corporate venture capital firm, Alexandria Venture Investments is a significant player in the life science and technology funding ecosystem. They are known for participating in multi-million dollar rounds, often alongside other top-tier venture capital firms. Their typical first check size for promising startups generally ranges from $1,000,000 for strong seed or early Series A rounds, up to $10,000,000 for more substantial Series A or early Series B investments, reflecting their commitment to providing meaningful capital to strategically aligned companies.